Abstract

Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists

Author(s): Huffman DC, Holmes Erin R

Issue: Nov/Dec 2006 - Veterinary Compounding

Page(s): 462-468

Download in electronic PDF format for $75
  • Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Page 1
  • Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Page 2
  • Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Page 3
  • Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Page 4
  • Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Page 5
  • Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Page 6
  • Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Page 7

Abstract

The apparent re-emergence of pharmaceutical compounding as an important part of health care is largely explained by the increasing demand for pharmaceutical preparations that are not commercially available. However, there have been recent discussions among regulatory agencies and various stakeholders of the pharmacy profession as to the safety and efficacy of pharmaceutical compounding, and how compounding should best be regulated. In light of this discussion, the American College of Apothecaries conducted a survey of International Journal of Pharmaceutical Compounding subscribers in July 2005 to (1) assess the safety and efficacy of compounded preparations, (2) describe the types of compounding and other professional services that are offered by pharmacists, and (3) describe selected compounding pharmacies. In general, respondents reported few incidents of adverse events resulting from compounded preparations, and reported having offered a variety of compounding, professional, and patient care specialties se

Related Keywords

  • American College of Apothecaries
  • pharmacist survey
  • compounding services
  • regulation
  • US Food and Drug Administration
  • accreditation standards
  • Pharmacy Compounding Accreditation Board
  • United States Pharmacopeia
  • specialty
  • adverse effects
  • revenue

Related Categories

  • BUSINESS
  • LEGAL
  • MARKETING
  • PEER-REVIEWED
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2008
Pg. 74-82
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Author(s): Huffman DC, Holmes Erin R
Nov/Dec 2006
Pg. 462-468
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Author(s): Huffman DC, Holmes Erin R
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2013
Pg. 339-343
Patient-centered Care as Value-added Service by Compounding Pharmacists
Author(s): McPherson Timothy B, Fontane Patrick E, Day Jonathan R
May/Jun 2014
Pg. 208
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Author(s): Miller David G
Jan/Feb 2018
Pg. 7-16
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Mar/Apr 2017
Pg. 95-102
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Author(s): Yoch Doug
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Jan/Feb 2010
Pg. 4
PreScription: American Pharmacists Assocation and Compounding: New Partnership Reflects Old Ties
Author(s): Menighan Thomas E
Nov/Dec 2015
Pg. 514-520
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Author(s): Lobb William B, Wilkin Noel E, Holmes Erin R
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Sep/Oct 2016
Pg. 367-374
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Author(s): Kochanowska-Karamyan Anna J
Jul/Aug 2020
Pg. 287-295
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
Author(s): McElhiney Linda F
Jul/Aug 2020
Pg. 296-297
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Author(s): Brunner Scott
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Sep/Oct 2015
Pg. 375
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding
Author(s): Miller David G
Jan/Feb 2023
Pg. 22-23
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Author(s): Brunner Scott